• Prostaglandin E2: Mechanistic Insights and Translational Str

  2026-06-02

  Explore how Prostaglandin E2 (PGE2) bridges fundamental mechanistic understanding with actionable guidance for translational researchers. Drawing on recent advances in inflammation modulation and cell signaling, this thought-leadership article outlines best practices for experimental design, competitive differentiation, and clinical translation—anchored by APExBIO’s validated PGE2 solution.

• Intestinal TM6SF2 Deficiency Drives MASH via Gut–Liver Axis

  2026-06-01

  The reference study uncovers how intestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis (MASH) by maintaining gut barrier integrity and regulating host–microbe interactions. This work clarifies a gut–liver axis mechanism linking local lipid metabolism, lysophosphatidic acid signaling, and hepatic inflammation, offering new directions for therapeutic research.

• Catalpol’s Mechanisms in Cancer: Apoptosis, Metastasis, and

  2026-06-01

  The referenced review systematically evaluates catalpol, a plant-derived iridoid glycoside, for its multi-faceted anticancer mechanisms across diverse models. By dissecting the compound’s influence on apoptosis, metastasis, inflammatory and oxidative pathways, the review clarifies catalpol’s promise as an experimental anticancer agent and highlights the need for translational research.

• Self-Microemulsifying Systems Enhance Luteolin Absorption vi

  2026-05-31

  This study presents a self-microemulsifying drug delivery system (SME) that significantly increases the oral bioavailability of luteolin by inhibiting P-glycoprotein-mediated efflux. The approach leverages D-α-tocopheryl polyethylene glycol 1000 succinate to overcome absorption barriers, offering a promising strategy for the delivery of poorly soluble bioactives.

• CXCR4-Targeted Theranostics in Lymphoma: Imaging and Precisi

  2026-05-30

  This article reviews recent advances in CXCR4-targeted imaging ligands and therapeutic agents for lymphoma, as detailed in the reference study. The integration of molecular imaging and precision therapy targeting CXCR4 is shown to improve diagnostic specificity and therapeutic efficacy, with implications for both hematologic and solid tumors.

• Strategic Applications of Angiotensin I in Translational Res

  2026-05-29

  This article explores the mechanistic insight and translational potential of Angiotensin I (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu), with a focus on its role in renin-angiotensin system research, cardiovascular disease modeling, and advanced drug screening. Drawing from recent peer-reviewed studies and expert protocols, it offers strategic guidance for researchers aiming to maximize the impact of Angiotensin I in both classic and emerging experimental domains.

• U 46619: Translating TP Receptor Biology into Research Impac

  2026-05-29

  This thought-leadership article explores how U 46619 (11,9 epoxymethano-prostaglandin H2) empowers translational researchers to dissect platelet and vascular mechanisms while navigating the evolving landscape of cardiovascular and renal modeling. By integrating mechanistic depth, experimental best practices, and strategic guidance, the piece frames U 46619 not just as a reagent, but as a pivotal tool for bridging preclinical insights and clinical promise.

• L-Ornithine: Mechanistic Insights and Translational Leverage

  2026-05-28

  This article explores the mechanistic role of L-Ornithine in the liver–brain metabolic axis, emphasizing its significance in translational research on ammonia detoxification, CNS toxicity, and metabolic enzyme assays. By integrating recent mechanistic findings, workflow guidance, and strategic perspectives, it offers actionable insights and protocol parameters for researchers seeking to bridge basic science with clinical impact.

• Sulfo-NHS-LC-Biotin: Practical Guide for Cell Surface Biotin

  2026-05-28

  Sulfo-NHS-LC-Biotin enables selective, irreversible labeling of primary amines on cell surface proteins in aqueous environments, making it ideal for workflows requiring stable biotinylation without organic solvents. It should not be used for intracellular or reversible labeling applications due to its membrane-impermeable and irreversible chemistry.

• Dronedarone (Multaq): Advanced Workflows for Arrhythmia Rese

  2026-05-27

  Dronedarone (Multaq) offers high-purity, workflow-ready performance for atrial fibrillation and flutter research, allowing scientists to model multi-ion channel modulation with precision. This article provides stepwise protocols, assay optimization tactics, and troubleshooting strategies, empowering translational advances in cardiac arrhythmia pharmacology.

• Olsalazine Sodium: Optimizing Cancer and Inflammation Assays

  2026-05-27

  This article guides life science researchers through real-world laboratory scenarios where Olsalazine Sodium (SKU A8490) provides data-backed reliability for cell-based assays in cancer and inflammation research. Drawing on recent literature and validated performance, we highlight how this mesalamine dimer addresses workflow challenges and supports reproducible results.

• 0.4% Trypan Blue Solution: Technical Guidance for Cell Viabi

  2026-05-26

  0.4% Trypan Blue Solution provides a rapid and reliable means to distinguish viable from non-viable cells during cell viability measurement and cell counting in research settings. This reagent is not suitable for diagnostic or clinical applications and should be used strictly for laboratory research workflows where live/dead cell discrimination is essential.

• Cell-to-Cell Transmission of Non-Constitutive Proteasomes vi

  2026-05-26

  The reference study demonstrates that non-constitutive proteasomes, particularly immunoproteasome subunits such as β5i (LMP7), can be transmitted between cells through extracellular vesicles (EVs). This finding reveals a novel mechanism for intercellular modulation of immune proteasome activity with implications for understanding antigen processing and immune regulation.

• Captopril as an ACE Inhibitor: Applied Workflows in Research

  2026-05-25

  Captopril is a benchmark ACE inhibitor that enables reliable hypertension and cancer research, while also serving as a tool to dissect bradykinin pathway modulation in gastrointestinal studies. This article details stepwise protocols, advanced applications, and troubleshooting strategies for maximizing data quality with APExBIO’s high-purity Captopril.

• Shisandra Decoction Modulates PI3K/AKT/mTOR in Parkinson’s M

  2026-05-25

  This study demonstrates that Shisandra Decoction alleviates motor deficits and reduces α-synuclein pathology in a mouse model of Parkinson’s disease by modulating the PI3K/AKT/mTOR signaling pathway. The findings highlight the decoction’s capacity to reverse autophagy abnormalities and suggest new mechanistic avenues for neuroprotective strategies in PD.

449 records 16/30 page Previous Next First page 上5页 1617181920 下5页 Last page